This is a delivery order contract (SPE2DB25FJMRZ) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price and a ceiling value of $4,112.43. It is not a set-aside contract.
This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical and medical products to support U.S. Armed Forces medical operations. The current delivery order is for the supply of a specific pharmaceutical product, XULANE 150-35 MCG/DAY PATCH 3S, with a performance period through November 14, 2024.
Generated 2/12/25, 9:32 AM